Intelligent Use of the Fecal Immunochemical Test in Population-Based Screening

Selby and colleagues examined clinical outcomes at various fecal immunochemical test thresholds and showed how other markers of risk in the screened population influence colorectal cancer detection rates. The editorialist believes that maximizing the cancer detection rate within the context of constrained endoscopy resources is a practical objective but that prevention through adenoma detection, as well as cost-effectiveness, also must be considered.

https://ift.tt/2QDNoy3